Bitcoin
As growth slows, CFO says Novo Nordisk is prepping for the next generation of weight loss drugs
![](https://fortune.com/img-assets/wp-content/uploads/2025/02/GettyImages-2186485157-e1738754056223.jpg?resize=1200,600)
Novo Nordisk’s Karsten Munk Knudsen is targeting 800 million obese people globally. Read More
Novo Nordisk’s Karsten Munk Knudsen is targeting 800 million obese people globally. Read More